Welcome
This survey asks about the screening for interstitial lung disease (ILD). Specifically, about screening people with rheumatoid arthritis (RA) for ILD.
As this topic is relevant to rheumatologists and respiratory physicians, we are asking both groups to contribute their views. If you are NOT a rheumatologist or respiratory physician or a registrar in either specialty, this survey is not for you.
This survey is the first step in a CPD activity worth 2.5 hours of reviewing performance (RP) and 0.5 hours as an educational activity (EA):
As this topic is relevant to rheumatologists and respiratory physicians, we are asking both groups to contribute their views. If you are NOT a rheumatologist or respiratory physician or a registrar in either specialty, this survey is not for you.
This survey is the first step in a CPD activity worth 2.5 hours of reviewing performance (RP) and 0.5 hours as an educational activity (EA):
- This survey (30 minutes of RP): rheumatologists and respiratory physicians reflect on their current practice when screening / diagnosing RA-ILD, and the applicability in Australia and potential barriers to implementing guidelines in Australia. Additional credit for 30 minutes of EA spent reviewing international guidelines is available.
- A webinar (90 minutes of RP): reflection on survey results in a peer-group learning activity.
- Post webinar survey (30 minutes of RP): comparing peer group views with personal views and reflecting on ways to improve practice.
Deidentified and aggregated results may be reported in scientific meetings and academic journals. Any personal information will be removed from the data to ensure your privacy. A more complete explanatory statement is available here.
We estimate that this survey will take approximately 30 minutes to complete. At the end of the survey, we will provide instructions to claim CPD credit.
Thank you for your time.